Pathological Crosstalk between Metastatic Breast Cancer Cells and the Bone Microenvironment

被引:36
作者
Zarrer, Jennifer [1 ]
Haider, Marie-Therese [1 ]
Smit, Daniel J. [2 ]
Taipaleenmaeki, Hanna [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Trauma Hand & Reconstruct Surg, Mol Skeletal Biol Lab, D-20246 Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Inst Biochem & Signal Transduct, D-20246 Hamburg, Germany
关键词
breast cancer; bone metastases; bone microenvironment; osteoclast; osteoblast; osteocyte; adipocyte; vasculature; hypoxia; nerve cells; MULTIPLE-MYELOMA PATIENTS; HYPOXIA-INDUCIBLE FACTOR; CATHEPSIN-K INHIBITOR; MARROW ADIPOCYTES; OSTEOCLAST DIFFERENTIATION; MOLECULAR-BIOLOGY; NERVOUS-SYSTEM; TUMOR-GROWTH; OSTEOBLAST; EXPRESSION;
D O I
10.3390/biom10020337
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone is the most common metastatic site in breast cancer. Upon arrival to the bone, disseminated tumor cells can undergo a period of dormancy but often eventually grow and hijack the bone microenvironment. The bone marrow microenvironment consists of multiple cell types including the bone cells, adipocytes, endothelial cells, and nerve cells that all have crucial functions in the maintenance of bone homeostasis. Tumor cells severely disturb the tightly controlled cellular and molecular interactions in the bone marrow fueling their own survival and growth. While the role of bone resorbing osteoclasts in breast cancer bone metastases is well established, the function of other bone cells, as well as adipocytes, endothelial cells, and nerve cells is less understood. In this review, we discuss the composition of the physiological bone microenvironment and how the presence of tumor cells influences the microenvironment, creating a pathological crosstalk between the cells. A better understanding of the cellular and molecular events that occur in the metastatic bone microenvironment could facilitate the identification of novel cellular targets to treat this devastating disease.
引用
收藏
页数:20
相关论文
共 129 条
[1]   IL-6 variant is associated with metastasis in breast cancer patients [J].
Abana, Chike O. ;
Bingham, Brian S. ;
Cho, Ju Hwan ;
Graves, Amy J. ;
Koyama, Tatsuki ;
Pilarski, Robert T. ;
Chakravarthy, A. Bapsi ;
Xia, Fen .
PLOS ONE, 2017, 12 (07)
[2]   Marrow adipocytes inhibit the differentiation of mesenchymal stem cells into osteoblasts via suppressing BMP-signaling [J].
Abdallah, Basem M. .
JOURNAL OF BIOMEDICAL SCIENCE, 2017, 24 :1-10
[3]   PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors [J].
Akune, T ;
Ohba, S ;
Kamekura, S ;
Yamaguchi, M ;
Chung, UI ;
Kubota, N ;
Terauchi, Y ;
Harada, Y ;
Azuma, Y ;
Nakamura, K ;
Kadowaki, T ;
Kawaguchi, H .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (06) :846-855
[4]   The bone metastasis niche in breast cancer: potential overlap with the haematopoietic stem cell niche in vivo [J].
Allocca, Gloria ;
Hughes, Russell ;
Wang, Ning ;
Brown, Hannah K. ;
Ottewell, Penelope D. ;
Brown, Nicola J. ;
Holen, Ingunn .
JOURNAL OF BONE ONCOLOGY, 2019, 17
[5]   Update on Bone Anabolics in Osteoporosis Treatment: Rationale, Current Status, and Perspectives [J].
Baron, Roland ;
Hesse, Eric .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (02) :311-325
[6]  
Bodenstine Thomas M, 2011, Chin J Cancer, V30, P189
[7]   Osteoclast differentiation and activation [J].
Boyle, WJ ;
Simonet, WS ;
Lacey, DL .
NATURE, 2003, 423 (6937) :337-342
[8]   Location matters: osteoblast and osteoclast distribution is modified by the presence and proximity to breast cancer cells in vivo [J].
Brown, H. K. ;
Ottewell, P. D. ;
Evans, C. A. ;
Holen, I. .
CLINICAL & EXPERIMENTAL METASTASIS, 2012, 29 (08) :927-938
[9]   Osteoblasts Are a Major Source of inflammatory Cytokines in the Tumor Microenvironment of Bone Metastatic Breast Cancer [J].
Bussard, Karen M. ;
Venzon, David J. ;
Mastro, Andrea M. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2010, 111 (05) :1138-1148
[10]   Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells [J].
Caers, J. ;
Deleu, S. ;
Belaid, Z. ;
De Raeve, H. ;
Van Valckenborgh, E. ;
De Bruyne, E. ;
DeFresne, M-P ;
Van Riet, I. ;
Van Camp, B. ;
Vanderkerken, K. .
LEUKEMIA, 2007, 21 (07) :1580-1584